20:29 , Jul 16, 2019 |  BC Extra  |  Financial News

July 16 Financial Quick Takes: J&J growth drivers beat consensus; plus Notable and Cradle raise funds

Imbruvica, Darzalex sales top analysts' consensus  In its 2Q19 earnings report, Johnson & Johnson (NYSE:JNJ) said revenue from its pharmaceutical segment grew to $10.53 billion during the quarter, up 1.7% compared with 2Q18, with newer...
22:41 , Jun 25, 2019 |  BC Extra  |  Financial News

June 25 Financial Quick Takes: Tasly unit planning Hong Kong IPO; plus Vesalius, Mirati and more

Tasly Biopharma looks to list in Hong Kong  Tasly Biopharmaceutical Co. Ltd. (Shanghai, China) proposed to list on the Hong Kong exchange. The company is a subsidiary of Tasly Pharmaceutical (Shanghai:600535), which holds 87.75% of...
20:04 , Apr 25, 2019 |  BC Innovations  |  Finance

The academic founders' conundrum

First-time academic entrepreneurs face a circular problem: while they’re continually sought after by VCs and pharmas seeking the next “big thing”, they also face an arduous path to establish their bona fides - not for...
00:36 , Nov 7, 2018 |  BC Extra  |  Company News

Management tracks: Five Prime, Alder

Five Prime Therapeutics Inc. (NASDAQ:FPRX) hired David Smith as EVP and CFO, effective Nov. 26. He will replace Linda Rubinstein, who was interim CFO of the cancer company. Smith was COO of IntegenX Inc. until...
20:01 , Nov 2, 2018 |  BC Week In Review  |  Financial News

Innovent shares rise in first day of Hong Kong trading

Innovent Biologics Inc. (HKSE:1801) gained HK$2.60 (19%) to HK$16.58 in its first day of trading Oct. 31, delivering the strongest first-day performance yet for a biotech listing on the Hong Kong stock exchange's new biotech...
14:19 , Oct 31, 2018 |  BC Extra  |  Financial News

Innovent shares rise in first day of Hong Kong trading

Innovent Biologics Inc. (HKSE:1801) gained HK$2.60 (19%) to HK$16.58 in its first day of trading Wednesday, delivering the strongest first-day performance yet for a biotech listing on the Hong Kong stock exchange's new biotech chapter....
19:35 , Aug 31, 2018 |  BC Week In Review  |  Financial News

China GL Capital claims 5% stake in U.K.'s Oxford BioDynamics

Epigenetic biomarker company Oxford BioDynamics plc (LSE:OBD) partnered with GL Capital Group to address demand for healthcare and personalized medicine in China. The Greater China healthcare-focused firm will act as the U.K.-based biotech's lead mainland...
18:44 , Aug 31, 2018 |  BC Week In Review  |  Financial News

China Biologic spurns acquisition proposal, seeks $590M raise

Plasma products company China Biologic Products Holdings Inc. (NASDAQ:CBPO) said it turned down an acquisition proposal made on Aug. 17, and said it is raising $590 million in a private placement. The Aug. 17 proposal...
20:15 , Aug 24, 2018 |  BC Extra  |  Company News

China Biologic spurns acquisition proposal, seeks $590M raise

Plasma products company China Biologic Products Holdings Inc. (NASDAQ:CBPO) said it turned down an acquisition proposal made last week, and said it is raising $590 million in a private placement. The Aug. 17 proposal to...
22:12 , Aug 22, 2018 |  BC Extra  |  Financial News

China's GL Capital claims 5% stake in U.K.'s Oxford BioDynamics

Epigenetic biomarker company Oxford BioDynamics plc (LSE:OBD) partnered with GL Capital Group to address demand for healthcare and personalized medicine in China. The Greater China healthcare-focused firm will act as the U.K.-based biotech's lead mainland...